GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the first bromodomain (BD1) of human BRD2 bound to RO3280

Analyse Crystal structure of the first bromodomain (BD1) of human BRD2 bound to RO3280 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7LAJ
Type
protein
Length
122 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 2
UniProt
U3KQA6
Ligands
79C
Pockets
1 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 55% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 2protein12255% helix, 2% strandU3KQA6

Ligands and binding sites

  • 79C · 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl) amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1990.500.811879C

Compared structures

  • 7LAJ · Crystal structure of the first bromodomain (BD1) of human BRD2 bound to Ro3280 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.